Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters September 28, 2026 Susilo Ahmad Tuberculosis remains a formidable global health crisis, persisting as one of the deadliest infectious diseases in human history despite six millennia of coexistence with our species. A team of researchers…
Sexual Health & Medical Wellness Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis September 21, 2026 Susilo Ahmad This breakthrough, detailed in a recent publication in the Journal of Clinical Investigation, represents a potential paradigm shift in the management of tuberculosis (TB), an ancient and persistent global health…
Sexual Health & Medical Wellness Breakthrough Intranasal DNA Vaccine Offers New Hope for Eradicating Drug-Tolerant Tuberculosis Persisters September 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine that could fundamentally shift the paradigm of tuberculosis…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
